Zacks Investment Research upgraded shares of Imperva Inc (NYSE:IMPV) from a hold rating to a strong-buy rating in a report released on Wednesday morning. Zacks Investment Research currently has $52.00 target price on the software maker’s stock.

According to Zacks, “Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company’s SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. “

Other research analysts have also recently issued research reports about the company. Evercore ISI reissued a buy rating and set a $56.00 price objective on shares of Imperva in a report on Friday, May 5th. Monness Crespi & Hardt increased their price objective on Imperva from $52.00 to $55.00 and gave the stock a buy rating in a report on Friday, May 5th. Royal Bank Of Canada increased their price objective on Imperva from $52.00 to $55.00 and gave the stock an outperform rating in a report on Friday, May 5th. TheStreet raised Imperva from a d rating to a c rating in a report on Thursday, May 4th. Finally, Imperial Capital reissued an outperform rating and set a $57.00 price objective (up previously from $55.00) on shares of Imperva in a report on Tuesday, May 9th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of Buy and a consensus target price of $50.39.

Imperva (IMPV) opened at 43.90 on Wednesday. The firm’s 50-day moving average price is $48.73 and its 200 day moving average price is $45.22. Imperva has a 52-week low of $34.40 and a 52-week high of $57.24. The company’s market cap is $1.48 billion.

Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.05 by $0.15. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The firm had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. During the same period in the prior year, the company earned ($0.23) EPS. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. On average, equities analysts predict that Imperva will post $0.81 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Imperva Inc (IMPV) Upgraded at Zacks Investment Research” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/05/imperva-inc-impv-upgraded-at-zacks-investment-research.html.

In other news, SVP Sunil D. Nagdev sold 4,857 shares of the stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $49.00, for a total transaction of $237,993.00. Following the transaction, the senior vice president now directly owns 16,290 shares in the company, valued at approximately $798,210. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CRO Michael D. Mooney sold 52,356 shares of the stock in a transaction dated Wednesday, May 10th. The shares were sold at an average price of $47.51, for a total value of $2,487,433.56. Following the transaction, the executive now owns 52,356 shares in the company, valued at $2,487,433.56. The disclosure for this sale can be found here. Insiders sold a total of 60,302 shares of company stock worth $2,875,861 over the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Several institutional investors have recently made changes to their positions in IMPV. Federated Investors Inc. PA raised its position in shares of Imperva by 340,350.0% in the second quarter. Federated Investors Inc. PA now owns 13,618 shares of the software maker’s stock valued at $652,000 after buying an additional 13,614 shares during the period. Turner Investments LLC purchased a new position in shares of Imperva during the second quarter valued at approximately $239,000. BNP Paribas Arbitrage SA raised its position in shares of Imperva by 1.8% in the second quarter. BNP Paribas Arbitrage SA now owns 204,573 shares of the software maker’s stock valued at $9,789,000 after buying an additional 3,646 shares during the period. Comerica Bank raised its position in shares of Imperva by 0.8% in the second quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock valued at $978,000 after buying an additional 157 shares during the period. Finally, Legal & General Group Plc raised its position in shares of Imperva by 27.2% in the second quarter. Legal & General Group Plc now owns 13,545 shares of the software maker’s stock valued at $649,000 after buying an additional 2,894 shares during the period. Hedge funds and other institutional investors own 92.72% of the company’s stock.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.